Emergent BioSolutions Inc (EBS)
4.345
-0.02
(-0.57%)
USD |
NYSE |
May 10, 16:00
4.345
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Shareholders Equity (Quarterly): 663.90M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 663.90M |
December 31, 2023 | 649.30M |
September 30, 2023 | 697.20M |
June 30, 2023 | 956.30M |
March 31, 2023 | 1.203B |
December 31, 2022 | 1.388B |
September 30, 2022 | 1.449B |
June 30, 2022 | 1.513B |
March 31, 2022 | 1.575B |
December 31, 2021 | 1.612B |
September 30, 2021 | 1.523B |
June 30, 2021 | 1.544B |
March 31, 2021 | 1.523B |
December 31, 2020 | 1.447B |
September 30, 2020 | 1.252B |
June 30, 2020 | 1.199B |
March 31, 2020 | 1.075B |
December 31, 2019 | 1.088B |
September 30, 2019 | 1.035B |
June 30, 2019 | 988.90M |
March 31, 2019 | 987.50M |
December 31, 2018 | 1.011B |
September 30, 2018 | 966.65M |
June 30, 2018 | 938.35M |
March 31, 2018 | 881.28M |
Date | Value |
---|---|
December 31, 2017 | 912.30M |
September 30, 2017 | 663.71M |
June 30, 2017 | 620.60M |
March 31, 2017 | 610.42M |
December 31, 2016 | 596.20M |
September 30, 2016 | 547.62M |
June 30, 2016 | 672.67M |
March 31, 2016 | 666.98M |
December 31, 2015 | 660.02M |
September 30, 2015 | 605.31M |
June 30, 2015 | 562.25M |
March 31, 2015 | 537.88M |
December 31, 2014 | 553.20M |
September 30, 2014 | 513.14M |
June 30, 2014 | 487.77M |
March 31, 2014 | 477.50M |
December 31, 2013 | 489.62M |
September 30, 2013 | 467.31M |
June 30, 2013 | 449.53M |
March 31, 2013 | 435.59M |
December 31, 2012 | 441.36M |
September 30, 2012 | 427.04M |
June 30, 2012 | 419.69M |
March 31, 2012 | 409.59M |
December 31, 2011 | 414.25M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
649.30M
Minimum
Dec 2023
1.612B
Maximum
Dec 2021
1.219B
Average
1.227B
Median
Shareholders Equity (Quarterly) Benchmarks
Avid Bioservices Inc | 180.17M |
Viking Therapeutics Inc | 933.89M |
FibroGen Inc | -228.12M |
Avinger Inc | -6.202M |
RAPT Therapeutics Inc | 147.04M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.804B |
Total Liabilities (Quarterly) | 1.140B |
Debt to Equity Ratio | 1.364 |
Current Ratio | 1.083 |
Net Debt Paydown Yield | 75.42% |